Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Eli Lilly and Company

NDC labeler code: 0002

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

135Products (NDC)

Prescription medicines

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
ApprovedApplicationMedicineSponsor
September 23, 2026BLA761408 Insulin efsitora alfa-gobe
ONSWIK
Eli Lilly and Co
April 1, 2026NDA220934 Orforglipron
FOUNDAYO
Eli Lilly and Co
September 25, 2025NDA218881 Imlunestrant
INLURIYO
Eli Lilly and Co
September 13, 2024BLA761306 Lebrikizumab-lbkz
EBGLYSS
Eli Lilly and Co
July 2, 2024BLA761248 Donanemab-azbt
KISUNLA
Eli Lilly Co
April 10, 2024NDA218160 Selpercatinib
RETEVMO
Eli Lilly and Co
November 8, 2023NDA217806 Tirzepatide
ZEPBOUND, ZEPBOUND (AUTOINJECTOR), ZEPBOUND KWIKPEN
Eli Lilly and Co
October 26, 2023BLA761279 Mirikizumab-mrkz
OMVOH
Eli Lilly and Co
January 27, 2023NDA216059 Pirtobrutinib
JAYPIRCA
Loxo Oncol
May 13, 2022NDA215866 Tirzepatide
MOUNJARO, MOUNJARO (AUTOINJECTOR), MOUNJARO KWIKPEN
Eli Lilly and Co
December 17, 2021BLA761215 Insulin glargine
REZVOGLAR
Eli Lilly Co
June 15, 2020BLA761109 Insulin lispro
LYUMJEV
Eli Lilly and Co
May 28, 2020NDA212123 Flortaucipir F-18
TAUVID
Avid Radiopharms Inc
May 8, 2020NDA213246 Selpercatinib
RETEVMO
Eli Lilly and Co
October 11, 2019NDA211280 Lasmiditan
REYVOW
Eli Lilly and Co
September 27, 2018BLA761063 Galcanezumab-gnlm
EMGALITY
Eli Lilly and Co
May 31, 2018NDA207924 Baricitinib
OLUMIANT
Eli Lilly and Co
September 28, 2017NDA208716 Abemaciclib
VERZENIO
Eli Lilly and Co
March 22, 2016BLA125521 Ixekizumab
TALTZ
Eli Lilly and Co
December 16, 2015BLA205692 Insulin glargine
BASAGLAR
Eli Lilly and Co
May 26, 2015BLA205747 Insulin lispro
HUMALOG KWIKPEN
Eli Lilly and Co
September 18, 2014BLA125469 Dulaglutide
TRULICITY
Eli Lilly and Co
April 21, 2014BLA125477 Ramucirumab
CYRAMZA
Eli Lilly and Co
April 6, 2012NDA202008 Florbetapir f 18
AMYVID
Avid Radiopharms Inc
February 4, 2004NDA021462 Pemetrexed
ALIMTA
Lilly
Show the other 8 applications
ApprovedApplicationMedicineSponsor
November 21, 2003NDA021368 Tadalafil
CIALIS
Lilly
November 26, 2002NDA021318 Teriparatide
FORTEO
Lilly
November 26, 2002NDA021411 Atomoxetine
STRATTERA
Lilly
December 22, 1999BLA021017 Insulin lispro
HUMALOG MIX 75/25, HUMALOG MIX 75/25 KWIKPEN, HUMALOG MIX 75/25 PEN
Lilly
December 22, 1999BLA021018 Insulin lispro
HUMALOG MIX 50/50, HUMALOG MIX 50/50 KWIKPEN, HUMALOG MIX 50/50 PEN
Lilly
December 9, 1997NDA020815 Raloxifene hydrochloride
EVISTA
Lilly
June 14, 1996BLA020563 Insulin lispro, Water
HUMALOG, HUMALOG KWIKPEN, HUMALOG PEN
Lilly
October 28, 1982BLA018780 Insulin human
HUMULIN R, HUMULIN R KWIKPEN, HUMULIN R PEN
Lilly

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2024

  1. March 12, 2024 · Class II · Completed · D-0445-2024 · Insulin lispro, Water

    CGMP Deviations

    Sterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection), Insulin Lispro Injection u-100, 10 mL, Use ONLY with Insulins listed on carton, Marketed by: Lilly USA, LLC, I

2022

  1. April 5, 2022 · Class II · Completed · D-0884-2022 · Dulaglutide

    TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions

    Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80

  2. April 5, 2022 · Class I · Completed · D-0882-2022 · Insulin lispro, Water

    TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

    Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-59

2021

  1. August 19, 2021 · Class II · Terminated · D-0773-2021 · Dulaglutide

    Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.

    Trulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026

FDA Enforcement Report search → · Report an error →